A.BlumenauerV.et al (2006)
Semaglutide led to a significant reduction in HbA1c levels compared to placebo- Patients receiving semaglutide experienced significant weight loss compared to those on placebo PIONEER Trials (Peptide Innovation for Early Diabetes Treatment): The PIONEER (Peptide Innovation for Early Diabetes Treatment) trials were a series of global, randomized, controlled clinical trials that investigated the efficacy, safety, and tolerability of oral semaglutide, a GLP-1 receptor agonist, in patients with type 2 diabetes
This helps increase elasticity to tighten and firm up skin
Glutathione monoethyl ester (5 mM) prevents Ethacrynic acid (HY-B1640)induced GSH depletion, ROS accumulation, and TDP43 nuclear clearance within 5 h, and restores GSH levels, reduces oxidative stress, prevents cell death, and normalizes TDP43 localization and GAPDH expression within 72 h in mouse motor neuronlike NSC34 cells [2]